State of the Art of Treatment of Acinetobacter baumannii Infections

Abstract Acinetobacter baumannii–calcoaceticus complex is the most commonly identified group of species within the genus Acinetobacter and has globally emerged as a major health care–associated pathogen. A. baumannii is the species most frequently responsible for human infections and has been classified by the World Health Organization as a critical–priority pathogen because of its remarkable ability to acquire antimicrobial resistance mechanisms and the high attributable mortality associated with its infections, which can reach 70% in critically ill patients. This section reviews the global and regional epidemiology of A. baumannii, its complex mechanisms of antimicrobial resistance, and current therapeutic strategies, with particular emphasis on newly approved antimicrobial agents.

Authors

Institutions

Publication Details

Journal
Seminars in Respiratory and Critical Care Medicine
Published
2026-11-12
DOI
https://doi.org/10.1055/a-2971-4336
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

State of the Art of Treatment of Acinetobacter baumannii Infections

Federica Portunato, Matteo Bassetti
Seminars in Respiratory and Critical Care Medicine
Antibiotic Resistance in Bacteria
article

State of the Art of Treatment of Acinetobacter baumannii Infections

Federica Portunato, Matteo Bassetti
article en

Abstract

Abstract Acinetobacter baumannii–calcoaceticus complex is the most commonly identified group of species within the genus Acinetobacter and has globally emerged as a major health care–associated pathogen. A. baumannii is the species most frequently responsible for human infections and has been classified by the World Health Organization as a critical–priority pathogen because of its remarkable ability to acquire antimicrobial resistance mechanisms and the high attributable mortality associated with its infections, which can reach 70% in critically ill patients. This section reviews the global and regional epidemiology of A. baumannii, its complex mechanisms of antimicrobial resistance, and current therapeutic strategies, with particular emphasis on newly approved antimicrobial agents.

Seminars in Respiratory and Critical Care Medicine
Ospedale Policlinico San Martino (IT), IRCCS Azienda Ospedaliera Metropolitana (IT), University of Genoa (IT)
Good health and well-being
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon